secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eloxx Pharmaceuticals, Inc. (ELOX)
CIK:        0001035354
Form:       8-K
Filed at:   2023-12-28T23:59:59+00:00
Accession:  0001104659-23-130052
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eloxx Pharma Chairman Tomer Kariv resigns from board effective Dec 27
---------------------------------------------------------------------

- Tomer Kariv resigned as Director, Chairman of the Board, and committee member effective December 27, 2023.
- Resignation is not due to any disagreement with the Company's operations, policies, or practices.
- Company's common stock currently quoted on OTC Pink following Nasdaq delisting appeal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1035354/000110465923130052/0001104659-23-130052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1035354/000110465923130052/tm2333866d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-130052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer